Myung Hee Lee, PhD

Overview

I am an Assistant Professor of Statistics in Clinical Epidemiology at Weill Cornell Medical College. I have a broad background in Statistics, with specific training and expertise in high dimensional, low sample data analysis. I received my Ph.D. from the University of North Carolina at Chapel Hill. I joined the bioinformatics group at the Lineberger Comprehensive Cancer Center, UNC-CH in 2007 shortly after graduation, and was a member of statistics faculty at Colorado State University from 2008-2015. The primary focus of my research is to develop statistical methodologies for high dimensional, low sample size data. My statistical work has been largely motivated by biological applications, particularly in analyzing high throughput data where the number of variables exceeds the sample size such as transcriptomics and metabolomics.

I am a faculty member in the Weill Cornell Center for Global Health where I am the primary statistician for the research projects. I also mentor clinical epidemiology graduate students, post docs, and junior faculty conducting research at our Center’s international sites (Brazil, Haiti, India, Tanzania).

Highlights

1
The Lancet. Global health · 2023
CECecilia Ew Nicol JAJennifer A Downs MHMyung Hee Lee
PMID: 37973342DOISenior author20 citations
2
The Journal of infectious diseases · 2024
KZKayvan Zainabadi KFKathleen F Walsh JWJean W. Pape DWDaniel W. Fitzgerald MHMyung Hee Lee
PMID: 38060827PMCID: PMC11326837DOISenior author8 citations
3
mBio · 2022
KZKayvan Zainabadi KSKohta Saito KFKathleen F Walsh JWJean W. Pape+2 more →MHMyung Hee Lee
PMID: 36326252PMCID: PMC9765512DOISenior author7 citations

Publications

92

Funding

18 View NIH portfolio on RePORTER ↗

Active

13 grants

Co-I
Determinants of TB Control, Relapse, and Reinfection
National Institute of Allergy and Infectious Diseases · 2026–2031
P01AI202868-06
Co-I
Schistosomiasis and Women's Reproductive Health
National Institute of Allergy and Infectious Diseases · 2024–2029Career
K24AI182638-01
Co-I
Impact of TB coinfection on HIV reservoir
National Institute of Allergy and Infectious Diseases · 2023–2028
R01AI176943-01A1
Co-I
A type 2 hybrid effectiveness-implementation trial of Community Health Workers to improve screening for postpartum diabetes in urban slums of India - Foreign Subsite Supplement
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028· 3 renewals
R01HD112141-03S1
KP
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2 - Foreign supplement
National Heart, Lung, and Blood Institute · 2018–2028· 3 renewals
R01HL143788-08S1
KP
Salicylate-based Drugs as Adjuvants to Potentiate Bedaquiline's Anti-TB Activity
National Institute of Allergy and Infectious Diseases · 2026–2028
R21AI190640-01A1
Co-I
Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities
National Heart, Lung, and Blood Institute · 2022–2027
R01HL161673-01
KP
Evaluating The Clinical Utility of A Novel RNA-Based Assay For Predicting TB Treatment Outcomes And Diagnosing Paucibacillary TB
CRDF Global · 2024–2027
202409-72792
Co-I
HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian Cohort
National Heart, Lung, and Blood Institute · 2021–2027
R01HL160332-01
KP
Tri-Institutional Tuberculosis Research Advancement Center
National Institute of Allergy and Infectious Diseases · 2022–2027
P30AI168433-01
KP
HIV and Women's Health
Fogarty International Center · 2022–2027· 2 renewals
D43TW011826-04S1
Co-I
Genital Immune, Mucosal, and Viral Effects of Female Genital Schistosomiasis in Tanzania
National Institute of Allergy and Infectious Diseases · 2022–2027
R01AI168306-01
Co-I
Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda - Foreign Subsite Supplement
National Institute of Mental Health · 2023–2026· 2 renewals
R01MH132440-04S1

Completed grants (5)

Co-I
Reducing Post-Hospital Mortality in HIV-Infected Adults in Tanzania
National Institute of Mental Health · 2018–2025
R01MH118107-01
KP
Global Health Research Training in HIV and Tuberculosis
National Institute of Allergy and Infectious Diseases · 2012–2024· 2 renewals
K24AI098627-06
Sub-PI
Learning Dynamics of Biological Processes from Time Course Omics Datasets
National Institute of General Medical Sciences · 2019–2023 · via Cornell University - Ithaca
R01GM135926-04
KP
Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in Haiti
Fogarty International Center · 2020–2023
R21TW011693-01
KP
Tri-Institutional TB Research Unit: Persistence and Latency
National Institute of Allergy and Infectious Diseases · 2020–2021
U19AI111143-06S1

News mentions

3 View all WCM news ↗

Diagnose to Cure: Developing RNA-based TB Testing
April 25, 2025
Weill Cornell Medicine investigators are developing a new test for TB that circumvents many of the current diagnostic challenges.
Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line Therapy
February 27, 2024
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti.
Working with Community Leaders Boosts Family Planning in Tanzania
November 16, 2023
Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania.